Alaunos Therapeutics Inc

TCRT
1,39
0,23 (19,83%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/2/202403:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/2/202422:44EDGAR2Form 8-K - Current report
20/2/202422:05EDGAR2Form 8-K - Current report
14/2/202418:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:58EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29/1/202414:45EDGAR2Form 8-K - Current report
23/1/202423:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202422:30EDGAR2Form 8-K - Current report
03/1/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:25EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202414:00EDGAR2Form 8-K - Current report
28/12/202322:30EDGAR2Form 8-K - Current report
22/12/202314:00EDGAR2Form 8-K - Current report
15/11/202313:30EDGAR2Form 8-K - Current report
14/11/202313:30GLOBEAlaunos Therapeutics Announces Third Quarter 2023 Financial..
28/9/202322:01EDGAR2Form 8-K - Current report
05/9/202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/9/202318:20EDGAR2Form 144 - Report of proposed sale of securities
14/8/202322:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:16EDGAR2Form 8-K - Current report
14/8/202322:05GLOBEAlaunos Therapeutics Announces Second Quarter 2023 Financial..
29/6/202313:00GLOBEAlaunos Therapeutics Announces Presentation at the 2nd..
25/5/202323:00GLOBEAlaunos Therapeutics to Present Early Data from TCR-T..
10/5/202313:00GLOBEAlaunos Therapeutics Reports First Quarter 2023 Financial..
03/5/202314:30GLOBEAlaunos Therapeutics to Report First Quarter 2023 Financial..
Apertura: 1,15 Min: 1,1345 Max: 1,34
Chiusura: 1,16

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network